跳至主要内容
临床试验/JPRN-UMIN000011462
JPRN-UMIN000011462招募中未知

The clinical study of the budesonide/formoterol combination drug additional dosage in the perioperative period in a lung cancer patient with COPD. - The clinical study of the budesonide/formoterol combination drug additional dosage in the perioperative period in a lung cancer patient with COPD.

Hamamatsu University School of Medicine0 个研究点目标入组 40 人开始时间: 2013年8月12日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patient that there is ICS/LABA mixing medicine in pre-administering within four weeks 2)Patient where exacerbation of COPD was admitted within four weeks 3)Patient that there is past of hypersensitivity in atropine, the kind edge material or tiotropium, budesonide or formoterol 4)Patient who has chronic ailments of lungs, heart, kidney, liver, and blood, etc. 5)Patient who has previous history of adrenal cortical insufficiency or accentuation syndrome 6)Patient who has glaucoma 7)Patient who has dysuria such as dysuria by enlarged prostate 8)Case who judged doctor in charge targets and it is improper

研究者

相似试验